CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN

Abstract

The article presents the review of clinical studies that determined the role of apixaban in the early treatment and long-term secondary prophylaxis of deep vein thrombosis and lower limbs and and/or pulmonary arteries embolism. It also defines a patient population for whom apixaban administration is justified on the basis of pilot studies and the clinical data accumulated to date at various clinics.

Keywords

• тромбоз глубоких вен
• тромбоэмболия легочных артерий
• пероральные антикоагулянты
• апиксабан